Oral bile acids in cystic fibrosis-associated liver disease.
Colombo
C
C
Department of Paediatrics, University of Milan, Italy.
Crosignani
A
A
Apostolo
M G
MG
Marzano
M T
MT
Bettinardi
N
N
Giunta
A
A
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000150:complications*; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy*; D010865:Pilot Projects; D016032:Randomized Controlled Trials as Topic; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use*
D014580:Ursodeoxycholic Acid